Wire Stories
Tarveda Therapeutics and SciClone Pharmaceuticals International Establish Licensing Agreement for PEN-866 in Greater China
SciClone granted exclusive license to co-develop and commercialize PEN-866 upon approval in the Greater China Region WATERTOWN, Mass.–(BUSINESS WIRE)–Tarveda Therapeutics, Inc. (“Tarveda”),...